Of course, we cannot eliminate that the activation of NLRP3 inflammasome exists in the liver or kidney after cardiac arrest at the molecular level, and pharmacologic blockage of NLRP3 inflammasome may exert a protective effect on these tissues. Here, NLRP3 is linked to cardiac arrest.